Purchase Order AG5615P150143
- Not listed
- Roche Diagnostics Corporation was awarded a $18,000 firm fixed-price purchase order by the Southeast Area civilian federal agency on June 17, 2015, for a Light Cycler PCR (polymerase chain reaction) system. The contract, with an ultimate completion date of September 15, 2015, represents a direct acquisition with no set-aside designation. Performance of the work is scheduled to occur in Castleton, Indiana. This purchase order falls within Roche Diagnostics' broader portfolio of federal diagnostic...
- This purchase order awarded Roche Diagnostics Corporation a firm fixed-price contract valued at $18,000 for one Roche LightCycler 96 Real Time PCR System (Catalog #5815916001), a molecular diagnostic instrument used for real-time polymerase chain reaction (PCR) testing. The contract, issued on April 29, 2015, with an ultimate completion date of May 8, 2015, was funded by a civilian federal agency's Southeast Area office and performed at a location in Castleton, Indiana. No small business...
- Roche Diagnostics Corporation was awarded a purchase order contract valued at $13,378.38 for LightCycler 480 Probes Master and LightCycler 480 Multiwell Plate supplies. The contract was awarded on September 7, 2018, with an ultimate completion date of September 27, 2018. This firm fixed-price contract was funded by a civilian federal agency under the Midwest Area and performed in Castleton, Indiana. No set-aside designation was used in this award, indicating open competition in the federal...
- Roche Diagnostics Corporation was awarded a $5.5K firm fixed price purchase order by a civilian federal agency within the Midwest Area on June 3, 2016, for a LightCycler 480-96 service agreement with quarterly payments. The contract, which did not utilize a set-aside designation, was completed by July 21, 2017, and performed in Castleton, Indiana. As a leading global manufacturer of in vitro diagnostic equipment and reagents, Roche Diagnostics provides the federal government with advanced...
- Roche Diagnostics Corporation received a $14.4K firm fixed-price delivery order from a civilian federal agency (Midwest Area) for a Roche LightCycler 480 II 96-well real-time PCR system with exchange of a Roche LightCycler 96 instrument. The order was awarded on April 5, 2021, with an ultimate completion date of June 1, 2021, and will be performed in Castleton, Indiana. This delivery order carries no set-aside designation and represents a child contract under the company's Multiple Award...
- This federal contract award was made by a civilian government agency to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The award is for the purchase of a Light Cycler 96 Instrument, with a ceiling value of $18,300.00. The contract is a firm fixed price purchase order without any set-aside designation, indicating open competition. Roche Diagnostics is a global leader...
- Roche Diagnostics Corporation was awarded a firm fixed-price purchase order valued at $15,697.84 for LightCycler 480 Probes Master on January 26, 2016, with an ultimate completion date of February 29, 2016. The contract was awarded by a civilian federal agency within the Midwest Area and will be performed in Castleton, Indiana. No set-aside designation was applied to this procurement, allowing Roche to compete openly in the federal marketplace. As a foreign-owned manufacturer of in vitro...
- Roche Diagnostics Corporation was awarded a firm fixed-price purchase order valued at $5,575.00 by a civilian federal agency (Midwest Area) for a Roche Service Plan covering the LC48 Real-Time PCR System Classic-Silver. The contract was awarded on September 27, 2016, with an ultimate completion date of August 26, 2017. The place of performance is Castleton, Indiana. This award was made without a set-aside designation, reflecting open competition in the federal marketplace. Roche Diagnostics...
- This is a $39,400 firm fixed-price purchase order awarded by the Plains Area of the U.S. Department of the civilian federal agency to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The award is for LIGHTCYCLER 480 and does not have a set-aside designation. Roche Diagnostics holds multiple significant indefinite delivery vehicles (IDVs) and blanket purchase agreements (BPAs) across federal agencies, including a...
- Roche Diagnostics Corporation received a firm fixed-price purchase order award from a civilian federal agency in the Midwest Area for LightCycler diagnostic equipment, valued at $18,300. The award, issued on June 25, 2018, with a completion date of August 31, 2018, was made without set-aside designation. Performance of the contract is located in Columbia, Missouri. As a foreign-owned manufacturer specializing in in vitro diagnostics and laboratory instruments, Roche Diagnostics supplies critical...
Roche Diagnostics Corporation was awarded a firm fixed-price purchase order valued at $5.5K on June 9, 2015, for LightCycler 48-96 coverage (Serial #26230) through a civilian federal agency's Midwest Area office. The contract period runs from July 22, 2015, through July 22, 2016, with performance to be completed in Castleton, Indiana. This award was made without set-aside designations, demonstrating open competition in the federal marketplace. The LightCycler system represents Roche's molecular diagnostic testing equipment, which is commonly utilized across federal healthcare systems for real-time polymerase chain reaction (PCR) applications and genetic analysis. As a child contract under a larger vehicle, this purchase order supports federal healthcare agencies' diagnostic capabilities by providing equipment coverage and associated services. Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory instruments, maintains an extensive portfolio of federal contracts primarily with the Department of Veterans Affairs and Defense Health Agency. The company supplies critical diagnostic technologies across multiple GSA Schedule contracts, including the Critical Analyzers, Laboratory and In Vitro Diagnostics, Reagents, Test schedules, enabling federal agencies to access pre-negotiated pricing for advanced laboratory testing and molecular diagnostic solutions that support medical research and patient care delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 6/9/15 |